271 related articles for article (PubMed ID: 27747393)
1. Exercise effects in Huntington disease.
Frese S; Petersen JA; Ligon-Auer M; Mueller SM; Mihaylova V; Gehrig SM; Kana V; Rushing EJ; Unterburger E; Kägi G; Burgunder JM; Toigo M; Jung HH
J Neurol; 2017 Jan; 264(1):32-39. PubMed ID: 27747393
[TBL] [Abstract][Full Text] [Related]
2. The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease.
Van Liew C; Gluhm S; Goldstein J; Cronan TA; Corey-Bloom J
Psychiatry; 2013; 76(4):323-35. PubMed ID: 24299091
[TBL] [Abstract][Full Text] [Related]
3. Exercise in Huntington's Disease: Current State and Clinical Significance.
Mueller SM; Petersen JA; Jung HH
Tremor Other Hyperkinet Mov (N Y); 2019; 9():601. PubMed ID: 30783551
[TBL] [Abstract][Full Text] [Related]
4. Exercise attenuates neuropathology and has greater benefit on cognitive than motor deficits in the R6/1 Huntington's disease mouse model.
Harrison DJ; Busse M; Openshaw R; Rosser AE; Dunnett SB; Brooks SP
Exp Neurol; 2013 Oct; 248():457-69. PubMed ID: 23911978
[TBL] [Abstract][Full Text] [Related]
5. Cognitive Dysfunction Contributes to Mobility Impairments in Huntington's Disease.
Kloos AD; Kegelmeyer DA; Fritz NE; Daley AM; Young GS; Kostyk SK
J Huntingtons Dis; 2017; 6(4):363-370. PubMed ID: 29254103
[TBL] [Abstract][Full Text] [Related]
6. Complex movement behaviour and progression of Huntington's disease.
Andrich J; Saft C; Ostholt N; Müller T
Neurosci Lett; 2007 Apr; 416(3):272-4. PubMed ID: 17321683
[TBL] [Abstract][Full Text] [Related]
7. Severity of cognitive impairment in juvenile and late-onset Huntington disease.
Gómez-Tortosa E; del Barrio A; García Ruiz PJ; Pernaute RS; Benítez J; Barroso A; Jiménez FJ; García Yébenes J
Arch Neurol; 1998 Jun; 55(6):835-43. PubMed ID: 9626775
[TBL] [Abstract][Full Text] [Related]
8. The effects of multidisciplinary rehabilitation in patients with early-to-middle-stage Huntington's disease: a pilot study.
Thompson JA; Cruickshank TM; Penailillo LE; Lee JW; Newton RU; Barker RA; Ziman MR
Eur J Neurol; 2013 Sep; 20(9):1325-9. PubMed ID: 23216520
[TBL] [Abstract][Full Text] [Related]
9. Effects of endurance training on skeletal muscle mitochondrial function in Huntington disease patients.
Mueller SM; Gehrig SM; Petersen JA; Frese S; Mihaylova V; Ligon-Auer M; Khmara N; Nuoffer JM; Schaller A; Lundby C; Toigo M; Jung HH
Orphanet J Rare Dis; 2017 Dec; 12(1):184. PubMed ID: 29258585
[TBL] [Abstract][Full Text] [Related]
10. Optimising mobility outcome measures in Huntington's disease.
Busse M; Quinn L; Khalil H; McEwan K
J Huntingtons Dis; 2014; 3(2):175-88. PubMed ID: 25062860
[TBL] [Abstract][Full Text] [Related]
11. 'Super-Enrichment' Reveals Dose-Dependent Therapeutic Effects of Environmental Stimulation in a Transgenic Mouse Model of Huntington's Disease.
Mazarakis NK; Mo C; Renoir T; van Dellen A; Deacon R; Blakemore C; Hannan AJ
J Huntingtons Dis; 2014; 3(3):299-309. PubMed ID: 25300333
[TBL] [Abstract][Full Text] [Related]
12. Clinical and genetic characteristics in patients with Huntington's disease from China.
Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
[TBL] [Abstract][Full Text] [Related]
13. The use of quantitative oculometry in the assessment of Huntington's disease.
Ali FR; Michell AW; Barker RA; Carpenter RH
Exp Brain Res; 2006 Feb; 169(2):237-45. PubMed ID: 16273398
[TBL] [Abstract][Full Text] [Related]
14. Supporting physical activity engagement in people with Huntington's disease (ENGAGE-HD): study protocol for a randomized controlled feasibility trial.
Busse M; Quinn L; Dawes H; Jones C; Kelson M; Poile V; Trubey R; Townson J; Edwards RT; Rosser A; Hood K
Trials; 2014 Dec; 15():487. PubMed ID: 25494622
[TBL] [Abstract][Full Text] [Related]
15. Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease.
Aziz NA; Anguelova GV; Marinus J; van Dijk JG; Roos RA
Eur J Neurol; 2010 Aug; 17(8):1068-74. PubMed ID: 20192977
[TBL] [Abstract][Full Text] [Related]
16. Unified Huntington's disease rating scale: clinical practice and a critical approach.
Klempír J; Klempírova O; Spacková N; Zidovská J; Roth J
Funct Neurol; 2006; 21(4):217-21. PubMed ID: 17367582
[TBL] [Abstract][Full Text] [Related]
17. Postural deficits in Huntington's disease when performing motor skills involved in daily living.
Panzera R; Salomonczyk D; Pirogovosky E; Simmons R; Goldstein J; Corey-Bloom J; Gilbert PE
Gait Posture; 2011 Mar; 33(3):457-61. PubMed ID: 21256027
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotection in Huntington's disease: a 2-year study on minocycline.
Bonelli RM; Hödl AK; Hofmann P; Kapfhammer HP
Int Clin Psychopharmacol; 2004 Nov; 19(6):337-42. PubMed ID: 15486519
[TBL] [Abstract][Full Text] [Related]
19. Weight loss in Huntington disease increases with higher CAG repeat number.
Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronic stress on the onset and progression of Huntington's disease in transgenic mice.
Mo C; Renoir T; Hannan AJ
Neurobiol Dis; 2014 Nov; 71():81-94. PubMed ID: 25088714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
